Pro Vice-Chancellor, College of Biomedical & Life Sciences

Professor Gary Baxter

Professor Gary Baxter is the Pro Vice-Chancellor for the College of Biomedical and Life Sciences.

Professor Baxter plays a key role in setting the strategy and direction of the College and in promoting the development of learning and teaching and research excellence. As Pro Vice-Chancellor, Professor Baxter is also a member of the University Executive Board.

Academic Schools

The College consists of nine Schools:

  • Biosciences
  • Dentistry
  • Healthcare Sciences
  • Medicine
  • Optometry and Vision Sciences
  • Pharmacy and Pharmaceutical Sciences
  • Postgraduate Medical and Dental Education/Wales Deanery
  • Psychology.

Research

Professor Baxter originally qualified in pharmacy at the University of Nottingham and The Royal London Hospital. After a period spent in clinical practice in hospitals in East Anglia, he undertook research training in experimental pharmacology. His Ph.D. was awarded in 1992 for research on cardiac rhythm disturbances in hypertension.

A recipient of the British Pharmacological Society's Bowman Prize and the Naranjan Dhalla Prize of the International Academy of Cardiovascular Sciences, Professor Baxter has served as European Secretary of the International Society for Heart Research and on the council of the European Society of Cardiology's Working Group on the Cellular Biology of the Heart, 2004-2009.

After a period spent at the Cape Heart Centre in South Africa, Professor Baxter was appointed Senior Lecturer in the Department of Medicine at UCL in 2000 and then Reader in Cardiovascular Biology at the Royal Veterinary College, University of London. Before joining Cardiff University, he was a British Heart Foundation research fellow at the Hatter Cardiovascular Institute and the Department of Physiology, UCL.

Professor Baxter’s research is focused on ischaemic heart disease and its treatment, with special emphasis on the molecular determinants of heart muscle injury during acute myocardial infarction (heart attack). He has published extensively on the roles of chemical signalling mechanisms relevant to the development of treatments to protect heart muscle. In 2009, the higher doctorate (D.Sc.) was conferred by the University of Nottingham for a body of published works on this topic and he was elected to Fellowships of the British Pharmacological Society, the Royal Pharmaceutical Society, the American Heart Association and the European Society of Cardiology.

An experienced university teacher, Professor Baxter is also committed to the broad aims of liberal education and has taught a wide range of topics, including aspects of physiology, pharmacology and philosophy of science, to natural sciences, medicine, veterinary science and pharmacy students.

Contact details

Personal Assistant: Shelley Stephens